Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human peripheral blood mononuclear cell (PBMC)-derived macrophages | Human | unknown | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | T. Troiani et al., British Journal of Cancer, 2020, 122: 1782–1790, doi.org/10.1038/s41416-020-0840-8 | Link | |||
Mouse podocytes | Mouse | urinary system | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | F. Kliewe et al., SCIENTIfIC REPORTS, nature.com, 7: 9916, DOI:10.1038/s41598-017-10116-4 | Link | |||
Mouse immortalized differentiated podocytes | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | J. G. Greiten et al., The FASEB Journal, 2021, 35: e21560, DOI: 10.1096/fj.202001179RR | Link | |||
Mouse primary brown adipocyte | Mouse | other | primary cell | siRNA | RNA-Interference | K2 Transfection System | publication | J. M. Olsen et al., J. Cell Biol., Nov 2014; 207: 365 - 374 | Link | ||||
Rat primary neonatal cardiomyocytes (isolated from the heart of 18-day-old embryos of Sprague-Dawley rats) | Rat | muscle | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Qiu et al., Cell Death and Differentiation, 2016, 23: 1658-1669, doi:10.1038/cdd.2016.56 | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Qiu et al., Cell Death and Differentiation, 2016, 23: 1658-1669, doi:10.1038/cdd.2016.56 | Link | |
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | application note | ![]() |
||
HeLa-229 |
Human cervix adenocarcinoma cell line (derivat of HeLa) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | D. Kaul et al., Blood Cells, Molecules and Diseases, 2015, 55: 89-93, doi.org/10.1016/j.bcmd.2015.05.001 | |||
hMSC |
Human mesenchymal stem cells | Human | unknown | stem cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., Exp. Cell Res., 2019, 385: 111683, doi.org/10.1016/j.yexcr.2019.111683 | Link | ||
hPASMC |
Human pulmonary artery smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | Z. Qian et al., Am. J. Physiol. Cell Physiol., July 2017, 313: C380 -C391; doi:10.1152/ajpcell.00061.2017 | |||
hPBMC |
Human peripheral blood monocyte-derived macrophages | Human | immune system | primary cell | siRNA | RNA-Interference | K2 Transfection System | publication | D. Pires et al., Scientific Reports, 2016, 6:32247, DOI: 10.1038/srep32247 | Link | |||
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Huang et al., Scientific Reports, 2019; 9: 4954, doi: 10.1038/s41598-019-40848-4 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Lutz, Dissertation, 2019, Technische Universität Darmstadt | Link |